Among the most frequently altered genes are well known oncogenes and tumor suppressors (e.g., MYC, TP53, and PTCH1) as well as novel medulloblastoma candidate genes (e.g., MML2) [5–10]. The gene discussed is MYC; the disease is medulloblastoma.